The prognostic value of lymph node staging with prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node‐positive patients with prostate cancer

• Published in: BJU international Vol. 131; no. 3; pp. 330 - 338
• Main Authors: Meijer, Dennie, Ettema, Rosemarijn H., Leeuwen, Pim J., Kwast, Theo H., Poel, Henk G., Donswijk, Maarten L., Oprea‐Lager, Daniela E., Bekers, Elise M., Vis, André N.
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.03.2023
• Subjects: Antigens; biochemical progression; Computed tomography; diameter of the largest nodal metastasis; extra‐nodal extension; Gallium Radioisotopes; Humans; Lymph Node Excision; Lymph nodes; Lymph Nodes - pathology; Lymphatic Metastasis - pathology; Lymphatic system; Male; Metastases; Metastasis; number of tumour‐positive lymph nodes; PCSM; pN1 disease; Positron emission tomography; Positron Emission Tomography Computed Tomography - methods; Prognosis; Prostate; Prostate - pathology; Prostate cancer; ProstateCancer; Prostatectomy; Prostatic Neoplasms - pathology; Regression analysis; Tomography; Tumors; uroonc; number of tumour-positive lymph nodes; pN1 disease; uroonc; PCSM; extra-nodal extension; ProstateCancer; biochemical progression; diameter of the largest nodal metastasis

Objectives To investigate whether patients with suspected pelvic lymph node metastases (molecular imaging [mi] N1) on staging prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) had a different oncological outcome compared to those in whom the PSMA PET...